Organization
Through its OEM partner, the company secured NMPA registrations for IVD use in China for its bone marrow aspirate DNA exaction kit and its DNA staining reagents.
In Brief This Week: Meridian Bioscience, BARDA, HHS, Oncocyte, GeneDx, More
News items for the week of Jan. 30, 2023.
LumiraDx Receives Notice From Nasdaq Over Missed Listing Requirement
The UK-based point-of-care diagnostics company received the letter because its common shares on the Nasdaq closed below $1 for 30 consecutive trading days.
An overwhelming volume of arbitration requests has made it difficult for providers, including labs, to quickly challenge and resolve payment disputes under the law.
NYU Langone Perlmutter Cancer Center to Validate Biological Dynamics Pancreatic Cancer Test
The collaboration will test retrospective samples from more than 200 patients to validate Biological Dynamics' platform.
Jan 23, 2023
AnPac Bio Receives Nasdaq Delisting Notice
Jan 19, 2023
Jan 12, 2023